This finding underscores the prognostic significance of pre-operative circulating carcinoembryonic antigen (CEA) levels in association with prognosis in CRC patients undergoing chemotherapy, as reported previously [26,27]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.